- Home
- CCCC vs FRD Comparison
CCCC vs FRD Comparison
Compare CCCC & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- FRD
- Stock Information
- Founded
- CCCC 2015
- FRD 1965
- Country
- CCCC United States
- FRD United States
- Employees
- CCCC N/A
- FRD N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- FRD Steel/Iron Ore
- Sector
- CCCC Health Care
- FRD Industrials
- Exchange
- CCCC Nasdaq
- FRD Nasdaq
- Market Cap
- CCCC 115.0M
- FRD 122.3M
- IPO Year
- CCCC 2020
- FRD N/A
- Fundamental
- Price
- CCCC $1.50
- FRD $15.81
- Analyst Decision
- CCCC Buy
- FRD
- Analyst Count
- CCCC 4
- FRD 0
- Target Price
- CCCC $12.50
- FRD N/A
- AVG Volume (30 Days)
- CCCC 1.3M
- FRD 18.7K
- Earning Date
- CCCC 05-07-2025
- FRD 06-10-2025
- Dividend Yield
- CCCC N/A
- FRD 1.01%
- EPS Growth
- CCCC N/A
- FRD N/A
- EPS
- CCCC N/A
- FRD 0.81
- Revenue
- CCCC $39,783,000.00
- FRD $447,616,000.00
- Revenue This Year
- CCCC N/A
- FRD N/A
- Revenue Next Year
- CCCC $36.31
- FRD N/A
- P/E Ratio
- CCCC N/A
- FRD $19.76
- Revenue Growth
- CCCC 98.56
- FRD N/A
- 52 Week Low
- CCCC $1.09
- FRD $12.24
- 52 Week High
- CCCC $7.66
- FRD $19.18
- Technical
- Relative Strength Index (RSI)
- CCCC 46.32
- FRD 45.63
- Support Level
- CCCC $1.42
- FRD $14.97
- Resistance Level
- CCCC $1.64
- FRD $16.56
- Average True Range (ATR)
- CCCC 0.15
- FRD 0.86
- MACD
- CCCC 0.02
- FRD -0.17
- Stochastic Oscillator
- CCCC 25.64
- FRD 48.53
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.